Mark Bernstein

17.3k total citations · 2 hit papers
325 papers, 11.1k citations indexed

About

Mark Bernstein is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mark Bernstein has authored 325 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Genetics, 66 papers in Pulmonary and Respiratory Medicine and 63 papers in Epidemiology. Recurrent topics in Mark Bernstein's work include Glioma Diagnosis and Treatment (96 papers), Meningioma and schwannoma management (58 papers) and Brain Metastases and Treatment (50 papers). Mark Bernstein is often cited by papers focused on Glioma Diagnosis and Treatment (96 papers), Meningioma and schwannoma management (58 papers) and Brain Metastases and Treatment (50 papers). Mark Bernstein collaborates with scholars based in Canada, United States and United Kingdom. Mark Bernstein's co-authors include Michael D. Taylor, Normand Laperrière, Demitre Serletis, Pirjo Manninen, Margaret Adams, Dorothy Barnard, L Brisson, Philip H. Gutin, Peter B. Dirks and Ian D. Clarke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Mark Bernstein

311 papers receiving 10.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE

1994 760 citations Mark Bernstein et al. profile →
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens

2009 756 citations Mark Bernstein et al. profile →

Peers

Countries citing papers authored by Mark Bernstein

Since Specialization

Citations

This map shows the geographic impact of Mark Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bernstein more than expected).

Fields of papers citing papers by Mark Bernstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bernstein. The network helps show where Mark Bernstein may publish in the future.

Co-authorship network of co-authors of Mark Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bernstein. A scholar is included among the top collaborators of Mark Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bernstein. Mark Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases 2024 ·Clinical and Translational Radiation Oncology ·(unknown), Aristotelis Kalyvas, (unknown), Kaiyun Yang, (unknown), (unknown), Barbara‐Ann Millar, Normand Laperrière, Tatiana Conrad, Alejandro Berlín, Jessica Weiss, Xuan Li, Gelareh Zadeh, Mark Bernstein, Paul Kongkham, David Shultz	0
2	Pituitary metastases: a case series and scoping review 2023 ·Pituitary ·Kaiyun Yang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Barbara‐Ann Millar, (unknown), Normand Laperrière, Mark Bernstein, Gelareh Zadeh, David Shultz, Paul Kongkham	7
3	Barriers and facilitators in the implementation of a telemedicine-based outpatient brain tumor surgery program 2022 ·Neurosurgical FOCUS ·Carla Mora, (unknown), (unknown), Rubén Martín‐Láez, (unknown), Lashmi Venkatraghavan, (unknown), (unknown), (unknown), Jesús Esteban‐Hernández, Blanca Moreno, (unknown), (unknown), Juan Martino, Gelareh Zadeh, Mark Bernstein, Carlos Velásquez	7
4	Augmented and virtual reality usage in awake craniotomy: a systematic review 2022 ·Neurosurgical Review ·Mohammad Mofatteh, (unknown), (unknown), Yimin Chen, Asfand Baig Mirza, Jawad Fares, Soham Bandyopadhyay, (unknown), (unknown), Mark Bernstein	14
5	Risk Factors and Characteristics of Intraoperative Seizures During Awake Craniotomy: A Retrospective Cohort Study of 562 Consecutive Patients With a Space-occupying Brain Lesion 2021 ·Journal of Neurosurgical Anesthesiology ·(unknown), Sudhakar Subramaniam, (unknown), (unknown), (unknown), Hirokazu Takami, Tumul Chowdhury, Mark Bernstein, Lashmi Venkatraghavan	10
6	Outcomes of presumed malignant glioma treated without pathological confirmation: a retrospective, single-center analysis 2020 ·Neuro-Oncology Practice ·(unknown), (unknown), Normand Laperrière, Mark Bernstein, Warren Mason	4
7	Patient perspectives on frame versus mask immobilization for gamma knife stereotactic radiosurgery 2020 ·Journal of medical imaging and radiation sciences ·Winnie Li, Angela Cashell, (unknown), (unknown), Catherine Coolens, Mark Bernstein, Paul Kongkham, Normand Laperrière, David Shultz	5
8	“No thanks, I don’t want to see snakes again”: a qualitative study of pain management versus preservation of cognition in palliative care patients 2020 ·BMC Palliative Care ·Pete Wegier, (unknown), Mark Bernstein, Peter G. Lawlor, Sarina R. Isenberg	12
9	Patient Perspectives Regarding Ethics of Spinal Column Stimulators in the Surgical Management of Persistent Postoperative Neuropathic Pain 2016 ·Neuromodulation Technology at the Neural Interface ·Nardin Samuel, Mark Bernstein, Naif M. Alotaibi, Suneil K. Kalia, Mohammed F. Shamji	6
10	Volume specific response criteria for brain metastases following salvage stereotactic radiosurgery and associated predictors of response 2012 ·Acta Oncologica ·Matthew Follwell, Kathleen Joy O. Khu, Lu Cheng, Wei Xu, David J. Mikulis, Barbara‐Ann Millar, May Tsao, Normand Laperrière, Mark Bernstein, Arjun Sahgal	28
11	Day Surgery Awake Craniotomy for Removing Brain Tumours: Technical Note Describing a Simple Protocol 2008 ·min - Minimally Invasive Neurosurgery ·Giorgio Carrabba, Lashmi Venkatraghavan, Mark Bernstein	51
12	Complications in 622 Cases of Frame-Based Stereotactic Biopsy, a Decreasing Procedure 2008 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Paul Kongkham, Eva Knifed, Mandeep S. Tamber, Mark Bernstein	82
13	The inappropriate distribution of magnetic resonance imaging resources in Ontario. 2004 ·PubMed ·Mark Bernstein, David J. Mikulis	1
14	Pain, nausea, vomiting and ocular complications delay discharge following ambulatory microdiscectomy 2003 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·(unknown), Frances Chung, (unknown), (unknown), Mark Bernstein	41
15	Generating Electric Power in the Pacific Northwest: Implications of Alternative Technologies 2002 ·Defense Technical Information Center (DTIC) ·Christopher G. Pernin, Mark Bernstein, (unknown), (unknown), (unknown)	0
16	The Public Benefit of California's Investments in Energy Efficiency 2000 ·Defense Technical Information Center (DTIC) ·Mark Bernstein, Robert J. Lempert, David S. Loughran, David S. Ortiz	13
17	Editor's Comments 1998 ·Neurosurgical FOCUS ·(unknown), Paul Ritvo, Mark Bernstein	6
18	Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study. 1998 ·Journal of Clinical Oncology ·(unknown), Daniel T. Casto, Paul J. Thomas, Steven Weitman, C. Kretschmar, Holcombe E. Grier, C B Pratt, Ronald L. Dubowy, Mark Bernstein, Susan M. Blaney, Teresa J. Vietti	15
19	Brachytherapy for Recurrent Single Brain Metastasis 1995 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Mark Bernstein, (unknown), Normand Laperrière, (unknown), (unknown)	36
20	An analysis of power plant efficiency and its policy implications 1984 ·University Microfilms International eBooks ·Mark Bernstein	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact